43 related articles for article (PubMed ID: 31928863)
1. Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
Qiu G; Li F; Kowah JAH; Xie J; Long Q; Wang L; Liu X
Bioorg Chem; 2024 May; 146():107276. PubMed ID: 38479132
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Molecular Docking, and Tumor Resistance Reversal Activity Evaluation of Matrine Derivative with Thiophene Structure.
Wei J; Liang Y; Wu L
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466857
[TBL] [Abstract][Full Text] [Related]
3. Alkaloids from Oxytropis ochrocephala and antiproliferative activity of sophoridine derivatives against cancer cell lines.
Tan CJ; Zhao Y; Goto M; Hsieh KY; Yang XM; Morris-Natschke SL; Liu LN; Zhao BY; Lee KH
Bioorg Med Chem Lett; 2016 Mar; 26(5):1495-7. PubMed ID: 26865176
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors.
Byrd KM; Kent CN; Blagg BSJ
ChemMedChem; 2017 Dec; 12(24):2022-2029. PubMed ID: 29058824
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
Zhang Z; Banerjee M; Davis RE; Blagg BSJ
Bioorg Med Chem Lett; 2019 Nov; 29(22):126676. PubMed ID: 31591016
[TBL] [Abstract][Full Text] [Related]
6. Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology.
Liu F; Li Y; Yang Y; Li M; Du Y; Zhang Y; Wang J; Shi Y
Drug Deliv; 2021 Dec; 28(1):325-342. PubMed ID: 33517789
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of alkylamino biphenylamides as Hsp90 C-terminal inhibitors.
Garg G; Zhao H; Blagg BS
Bioorg Med Chem; 2017 Jan; 25(2):451-457. PubMed ID: 27914946
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembled Matrine-PROTAC Encapsulating Zinc(II) Phthalocyanine with GSH-Depletion-Enhanced ROS Generation for Cancer Therapy.
Lai S; Wang B; Sun K; Li F; Liu Q; Yu XA; Jiang L; Wang L
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675664
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.
Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M
J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of matrine contains benzimidazole derivatives as dual TOPOI and PARP inhibitors for cancer therapy.
Qiu G; Xie J; Li F; Han K; Long Q; Kowah JAH; Gao R; Wang L; Liu X
Eur J Med Chem; 2024 Apr; 270():116348. PubMed ID: 38554475
[TBL] [Abstract][Full Text] [Related]
11. Development of VER-50589 analogs as novel Hsp90 inhibitors.
Fang X; Feng J; Wang K; Luan Y
Bioorg Med Chem Lett; 2023 Jul; 91():129375. PubMed ID: 37315698
[TBL] [Abstract][Full Text] [Related]
12. Identification and Structure-Activity Studies of 1,3-Dibenzyl-2-aryl imidazolidines as Novel Hsp90 Inhibitors.
Liu Y; Liu X; Li L; Dai R; Shi M; Xue H; Liu Y; Wang H
Molecules; 2019 Jun; 24(11):. PubMed ID: 31163701
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.
Sellers RP; Alexander LD; Johnson VA; Lin CC; Savage J; Corral R; Moss J; Slugocki TS; Singh EK; Davis MR; Ravula S; Spicer JE; Oelrich JL; Thornquist A; Pan CM; McAlpine SR
Bioorg Med Chem; 2010 Sep; 18(18):6822-56. PubMed ID: 20708938
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Inhibition of Hsp90 Protein by Benzothiazoloquinazolinequinones Is Enhanced in The Presence of Ascorbate. A Preliminary In Vivo Antiproliferative Study.
Valderrama JA; Ríos D; Muccioli GG; Buc Calderon P; Benites J
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093392
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the Thermal Stability and Aqueous Solubility of Three Matrine Salts Assembled by the Similar Structure Salt Formers.
Wang Y; Zhang B; Wang W; Yuan P; Hu K; Zhang L; Yang D; Lu Y; Du G
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256926
[TBL] [Abstract][Full Text] [Related]
16. Application of Quinoline Ring in Structural Modification of Natural Products.
Zhao YQ; Li X; Guo HY; Shen QK; Quan ZS; Luan T
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764254
[TBL] [Abstract][Full Text] [Related]
17. Target Discovery of Matrine against PRRSV in Marc-145 Cells via Activity-Based Protein Profiling.
Ling X; Cao Z; Sun P; Zhang H; Sun Y; Zhong J; Yin W; Fan K; Zheng X; Li H; Sun N
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511286
[TBL] [Abstract][Full Text] [Related]
18. New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment.
Xu Y; Jing D; Zhao D; Wu Y; Xing L; Ur Rashid H; Wang H; Wang L; Cao H
Bioorg Med Chem; 2020 Feb; 28(4):115305. PubMed ID: 31928863
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
Li Z; Luo M; Cai B; Wu L; Huang M; Haroon-Ur-Rashid ; Jiang J; Wang L
Bioorg Med Chem Lett; 2018 Feb; 28(4):677-683. PubMed ID: 29395978
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
